Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Uxin (UXIN) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Uxin (UXIN) over the last 8 years, with Q3 2025 value amounting to $10.7 billion.

  • Uxin's Cash & Equivalents rose 25795595.75% to $10.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 billion, marking a year-over-year increase of 25795595.75%. This contributed to the annual value of $3.4 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Uxin's Cash & Equivalents stood at $10.7 billion, which was up 25795595.75% from $9.5 million recorded in Q2 2025.
  • In the past 5 years, Uxin's Cash & Equivalents ranged from a high of $10.7 billion in Q3 2025 and a low of $92.71 during Q1 2023
  • Over the past 5 years, Uxin's median Cash & Equivalents value was $16.7 million (recorded in 2021), while the average stood at $1.6 billion.
  • As far as peak fluctuations go, Uxin's Cash & Equivalents tumbled by 9998.99% in 2022, and later soared by 25795595.75% in 2025.
  • Quarter analysis of 5 years shows Uxin's Cash & Equivalents stood at $148.9 million in 2021, then tumbled by 99.99% to $15088.0 in 2022, then increased by 28.25% to $19350.0 in 2023, then surged by 17677.78% to $3.4 million in 2024, then skyrocketed by 310917.44% to $10.7 billion in 2025.
  • Its Cash & Equivalents stands at $10.7 billion for Q3 2025, versus $9.5 million for Q2 2025 and $14.2 million for Q1 2025.